Scopus Financial Statements From 2010 to 2026
| SCPS Stock | USD 0.0004 0.00 0.00% |
Check Scopus Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Scopus Biopharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Scopus financial statements analysis is a perfect complement when working with Scopus Biopharma Valuation or Volatility modules.
Scopus |
Scopus Biopharma OTC Stock Return On Equity Analysis
Scopus Biopharma's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Scopus Biopharma Return On Equity | -15.6 |
Most of Scopus Biopharma's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Scopus Biopharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Scopus Biopharma has a Return On Equity of -15.596. This is 34.94% lower than that of the Healthcare sector and 57.22% lower than that of the Biotechnology industry. The return on equity for all United States stocks is notably higher than that of the company.
Scopus Biopharma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Scopus Biopharma's current stock value. Our valuation model uses many indicators to compare Scopus Biopharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Scopus Biopharma competition to find correlations between indicators driving Scopus Biopharma's intrinsic value. More Info.Scopus Biopharma is rated third in return on equity category among its peers. It is currently regarded as top stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Scopus Biopharma's earnings, one of the primary drivers of an investment's value.About Scopus Biopharma Financial Statements
Scopus Biopharma shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Scopus Biopharma investors may analyze each financial statement separately, they are all interrelated. The changes in Scopus Biopharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on Scopus Biopharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. Scopus BioPharma Inc. was incorporated in 2017 and is headquartered in New York, New York. Scopus Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Scopus OTC Stock Analysis
When running Scopus Biopharma's price analysis, check to measure Scopus Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scopus Biopharma is operating at the current time. Most of Scopus Biopharma's value examination focuses on studying past and present price action to predict the probability of Scopus Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scopus Biopharma's price. Additionally, you may evaluate how the addition of Scopus Biopharma to your portfolios can decrease your overall portfolio volatility.